IGF2BP3 and neoplasm: After adjusting for clinical variables, including age, sex, tumor grade, pathological stage, and T stage, univariate (P < 0.001) and multivariate (P < 0.05) Cox analyses showed that IGF2BP3 was an independent predictor of overall survival (Fig. 2B).